FDA Issues Warning Letter on Unapproved Breast Implant Device

February 19, 2019 | Steven Shapiro | FDA | Litigation | Medical Devices and Wearables

Last week, the U.S. Food and Drug Administration (FDA) announced that it issued a warning letter to Mark Berman, M.D., a Beverly Hills, Calif., cosmetic surgeon, for illegally marketing an unapproved implantable device. Dr. Berman claims that the “Pocket Protector” can prevent and treat capsular contracture (tightening of scar tissue), a complication of breast implants.

In the letter, the FDA stated that it is “not aware of an implantable device intended for use with breast implants . . . that is legally marketed for this use.” Therefore, the device requires premarket approval as a class III medical device.

In addition to the violations noted in this warning letter, Dr. Berman is currently the subject of a separate federal enforcement case pertaining to marketing of other FDA-regulated products without FDA approval. In that case, the U.S. is seeking a permanent injunction against Dr. Berman and his California Stem Cell Treatment Center to stop them from marketing unapproved stem cell products.

Authors
show more

Get legal updates and news delivered to your inbox